Physician profile
Frank Charles Lucente
NPI 1306932140
$2,850.33
in general payments reported to CMS, 2019-2025
8 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.68 · 2023: $1,763 · 2024: $739 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,432 · Food and Beverage: $1,132 · Education: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,431.78 |
| Food and Beverage | $1,132.40 |
| Education | $252.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,248.93 | 2022-2025 | Da Vinci Surgical System |
| Organogenesis INC. | $386.85 | 2023-2024 | Puraply, Affinity |
| Atricure, INC. | $93.79 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Solventum Corporation | $47.82 | 2024-2025 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Smith+Nephew, INC. | $24.06 | 2024 | Collagenase Santyl |
| Pacira Pharmaceuticals Incorporated | $18.17 | 2025 | Exparel |
| Kls-Martin L.P. | $16.69 | 2024 | |
| Tela Bio, INC. | $14.02 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Lucente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.